Canada Pension Plan Investment Board’s Caris Life Sciences CAI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$24.5M Buy
1,374,952
+52,200
+4% +$934K 0.01% 519
2026
Q1
$23.7M Sell
1,322,752
-141,806
-10% -$3.1M 0.02% 467
2025
Q4
$39.5M Buy
1,464,558
+141,806
+11% +$3.99M 0.03% 384
2025
Q3
$40M Hold
1,322,752
– – 0.03% 382
2025
Q2
$35.3M Buy
+1,322,752
New +$35.6M 0.03% 372

Other funds holding CAI

Canada Pension Plan Investment Board's CAI Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its Caris Life Sciences (CAI) stake by 3.9% in Q2 2026, buying an estimated $934K and bringing the position to 1,374,952 shares worth $24.5M. The position accounts for 0.01% of the portfolio, ranked #519.

Canada Pension Plan Investment Board first reported a position in CAI in Q2 2025 and has held it in 5 quarters since. The position peaked at $40M in Q3 2025. 247 funds tracked by Wall St. Rank hold CAI as of Q2 2026.

  • Canada Pension Plan Investment Board held 1,374,952 shares of Caris Life Sciences worth $24.5M as of Q2 2026.
  • Canada Pension Plan Investment Board bought 52,200 Caris Life Sciences shares in Q2 2026, an estimated $934K.
  • Caris Life Sciences made up 0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #519 holding.
  • Canada Pension Plan Investment Board first reported a position in Caris Life Sciences in Q2 2025 and has held it in 5 quarters since.
  • Canada Pension Plan Investment Board's Caris Life Sciences position peaked at $40M in Q3 2025.
  • 247 funds tracked by Wall St. Rank held Caris Life Sciences as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.